Genenta Science S.p.A. (GNTA) Financials
GNTA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-06-30 | 29.1 million | 2.1 million |
| 2023-03-31 | 36.4 million | 2.5 million |
| 2022-12-31 | 35.9 million | 2.5 million |
| 2022-09-30 | 32795 | 2254 |
GNTA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-06-30 | -8.2 million | 226 |
| 2023-03-31 | -2657 | 262 |
| 2022-12-31 | ? | ? |
| 2022-09-30 | -2391 | 236 |
GNTA Net Income
No data available :(
GNTA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-06-30 | 24.2 million | - | - |
| 2023-03-31 | 32.5 million | - | - |
| 2022-12-31 | 32.0 million | - | - |
| 2022-09-30 | 29222 | - | - |
GNTA Shares Outstanding
GNTA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-06-30 | 13397 | 4.2 million | 1564 | 3.1 million |
| 2023-03-31 | 13 | 2015 | 1738 | - |
| 2022-12-31 | 13015 | - | - | - |
| 2022-09-30 | 11 | 1813 | 1564 | - |
GNTA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-06-30 | - | 22775 |
| 2023-03-31 | - | - |
| 2022-12-31 | - | - |
| 2022-09-30 | - | - |
GNTA
Price: $3.56
52 week price:
Earnings Per Share: -0.69 USD
P/E Ratio: -4.57
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 5118
Market Capitalization: 63.3 million